Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC-OS): an Asia Pacific study of postmenopausal women treated for osteoporosis in clinical practice - MUSIC-AP Study

Merck Sharp and Dohme0 个研究点目标入组 3,600 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Postmenopausal women, defined as no menstruation for the last 12 months.
•At least 50 years of age at enrollment.
•Determined to have osteoporosis based on their physicians judgment (with or without bone mineral density evaluation)
•For the untreated group, participants should be treatment naÃ¯ve for Osteoporosis medications.
•For the treated group, patients are divided into new users and experienced users.
•For the new user cohort participants should be taking osteoporosis medications for less than 3 months and should be treatment naive prior to commencing therapy. Experienced Users are participants who have been receiving the same oral pharmacological therapy for at least 3 months continuously and are continuing treatment at the time of enrollment
•Willing and able to complete all scheduled followup questionnaire assessments during the 12 month followup (except for untreated participants).
•Willing to provide informed consent and be willing and able to follow the study protocol.

•1)Diagnosed with Parkinsonâ??s disease or any other neuromuscular disease.
•2)Diagnosed with Pagetâ??s disease.
•3)Currently or previously diagnosed with a malignant neoplasm
•4)Currently treated with any injectable medication for osteoporosis including intravenous bisphosphonates, subcutaneous PTH or denosumab (Refer to Appendix 2 for a list of injectable medications for osteoporosis).
•5)Switched between oral pharmacological osteoporosis medications having different active ingredients within the 3 months prior to study entry.
•6)Considered by the investigator to be unwilling or unable to complete the study or comply with the protocol.
•7)Involved in any active litigation or compensation issues including disability dispute cases with government.
•8)Currently enrolled in an interventional clinical trial or have participated in an interventional clinical trial within the past 3 months.

发起方

Merck Sharp and Dohme